B
BLLN
vs
S&P 500
S&P 500
Over the past 12 months, BLLN has underperformed S&P 500, delivering a return of -21% compared to the S&P 500's +12% growth.
Stocks Performance
BLLN vs S&P 500
Performance Gap
BLLN vs S&P 500
Performance By Year
BLLN vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
BillionToOne Inc
Glance View
BillionToOne Inc is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Menlo Park, California. The company went IPO on 2025-11-06. BillionToOne Inc is a United States-based precision diagnostics company. The firm provides Quantitative Counting Template (QCT) molecular counter platform, is the only technology platform that can count deoxyribonucleic acid (DNA) molecules to the single-count level and detect risk for common and severe genetic diseases. The Company’s product UNITY, is a noninvasive prenatal screening that tests fetal cell-free DNA for cystic fibrosis (CF) and spinal muscular atrophy (SMA) through a single sample of the mother's blood.
